| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adenosine monophosphate deaminase 3 null mutation causes reduction of naive T cells in mouse peripheral blood
|
Zhan, Xiaoming
|
|
|
4 |
15 |
p. 3594-3605
|
artikel
|
| 2 |
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
|
Sekeres, Mikkael A.
|
|
|
4 |
15 |
p. 3528-3549
|
artikel
|
| 3 |
An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms
|
von Drygalski, Annette
|
|
|
4 |
15 |
p. 3716-3727
|
artikel
|
| 4 |
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma
|
Villa, Diego
|
|
|
4 |
15 |
p. 3486-3494
|
artikel
|
| 5 |
Bosticardo M, Pala F, Calzoni E, et al. Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020;4(12):2611-2616.
|
|
|
|
4 |
15 |
p. 3507
|
artikel
|
| 6 |
Cell interactions in the bone marrow microenvironment affecting myeloid malignancies
|
Kokkaliaris, Konstantinos D.
|
|
|
4 |
15 |
p. 3795-3803
|
artikel
|
| 7 |
Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay
|
Gao, Wenwen
|
|
|
4 |
15 |
p. 3659-3667
|
artikel
|
| 8 |
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities
|
Abdallah, Nadine
|
|
|
4 |
15 |
p. 3509-3519
|
artikel
|
| 9 |
Development and validation of a universal blood donor genotyping platform: a multinational prospective study
|
Gleadall, Nicholas S.
|
|
|
4 |
15 |
p. 3495-3506
|
artikel
|
| 10 |
Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patients
|
Langereis, Jeroen D.
|
|
|
4 |
15 |
p. 3615-3620
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
4 |
15 |
p. i
|
artikel
|
| 12 |
End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies
|
Egan, Pamela C.
|
|
|
4 |
15 |
p. 3606-3614
|
artikel
|
| 13 |
Exploitable metabolic dependencies in MLL-ENL–induced leukemia
|
Garcia-Cuellar, Maria-Paz
|
|
|
4 |
15 |
p. 3626-3638
|
artikel
|
| 14 |
Gene therapy for hemophilia: anticipating the unexpected
|
Pierce, Glenn F.
|
|
|
4 |
15 |
p. 3788
|
artikel
|
| 15 |
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
|
Jain, Tania
|
|
|
4 |
15 |
p. 3776-3787
|
artikel
|
| 16 |
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
|
Guermouche, Hélène
|
|
|
4 |
15 |
p. 3550-3557
|
artikel
|
| 17 |
Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses
|
Phan, Vien
|
|
|
4 |
15 |
p. 3572-3585
|
artikel
|
| 18 |
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
|
Ferreri, Andrés J.M.
|
|
|
4 |
15 |
p. 3648-3658
|
artikel
|
| 19 |
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure
|
Simonin, Mathieu
|
|
|
4 |
15 |
p. 3621-3625
|
artikel
|
| 20 |
Iron deficiency following bariatric surgery: a retrospective cohort study
|
Gowanlock, Zachary
|
|
|
4 |
15 |
p. 3639-3647
|
artikel
|
| 21 |
Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma
|
Meriranta, Leo
|
|
|
4 |
15 |
p. 3742-3753
|
artikel
|
| 22 |
Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation
|
Zou, Jun
|
|
|
4 |
15 |
p. 3474-3485
|
artikel
|
| 23 |
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
|
Debureaux, Pierre-Edouard
|
|
|
4 |
15 |
p. 3708-3715
|
artikel
|
| 24 |
Nakajima R, Moskowitz AJ, Michaud L, et al. Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information. Blood Adv. 2020;4(8):1812-1823.
|
|
|
|
4 |
15 |
p. 3558
|
artikel
|
| 25 |
Neutrophils lacking ERM proteins polarize and crawl directionally but have decreased adhesion strength
|
Panicker, Sumith R.
|
|
|
4 |
15 |
p. 3559-3571
|
artikel
|
| 26 |
Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trial
|
Hasan, Rida
|
|
|
4 |
15 |
p. 3767-3775
|
artikel
|
| 27 |
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure
|
Shaw, Joseph R.
|
|
|
4 |
15 |
p. 3520-3527
|
artikel
|
| 28 |
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
|
Benz, Rudolf
|
|
|
4 |
15 |
p. 3699-3707
|
artikel
|
| 29 |
Prospective phase 2 trial of ixazomib after nonmyeloablative haploidentical peripheral blood stem cell transplant
|
Solomon, Scott R.
|
|
|
4 |
15 |
p. 3669-3676
|
artikel
|
| 30 |
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features
|
Coltro, Giacomo
|
|
|
4 |
15 |
p. 3677-3687
|
artikel
|
| 31 |
Red blood cell adhesion to ICAM-1 is mediated by fibrinogen and is associated with right-to-left shunts in sickle cell disease
|
Kucukal, Erdem
|
|
|
4 |
15 |
p. 3688-3698
|
artikel
|
| 32 |
Silasi R, Keshari RS, Lupu C, et al. Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death. Blood Adv. 2019;3(4):658-669.
|
|
|
|
4 |
15 |
p. 3741
|
artikel
|
| 33 |
Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study
|
Bergsten, Elisabet
|
|
|
4 |
15 |
p. 3754-3766
|
artikel
|
| 34 |
Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
|
Vara, Nitza
|
|
|
4 |
15 |
p. 3728-3740
|
artikel
|
| 35 |
The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease
|
Zeiser, Robert
|
|
|
4 |
15 |
p. 3789-3794
|
artikel
|
| 36 |
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery
|
Wilson, Matthew R.
|
|
|
4 |
15 |
p. 3586-3593
|
artikel
|
| 37 |
Vander Lugt MT, Chen X, Escolar ML, et al. Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders. Blood Adv. 2020;4(13):3041-3052.
|
|
|
|
4 |
15 |
p. 3508
|
artikel
|
| 38 |
Von Drygalski A, Giermasz A, Castaman G, et al. Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Adv. 2019;3(21):3241-3247.
|
|
|
|
4 |
15 |
p. 3668
|
artikel
|
Tijdschrift beschrijving